Open AccessSARS-CoV-2: an imperative maternal-fetal concern
Author(s) -
Zahra Heydarifard,
Jila Yavarian,
Somayeh Shatizadeh Malekshahi,
Sevrin Zadheidar,
Talat MokhtariAzad,
Nazanin Zahra ShafieiJandaghi
Publication year - 2021
Publication title -
iranian journal of microbiology.
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.37
H-Index - 27
eISSN - 2008-4447
pISSN - 2008-3289
DOI - 10.18502/ijm.v13i4.6963
Subject(s) - coronaviridae , pregnancy , betacoronavirus , medicine , fetus , coronavirus , population , pandemic , transmission (telecommunications) , disease , intensive care medicine , immunology , virology , covid-19 , biology , infectious disease (medical specialty) , environmental health , electrical engineering , genetics , engineering
Severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) is a newly emerged virus which belongs to Coronaviridae family within the betacoronavirus genus. Previous reports demonstrated that other betacoronaviruses were responsible for adverse outcomes during pregnancy in human. Due to inadequate data, the consequences of a SARS-CoV-2 infection during pregnancy is still a public health concern in the second year of SARS-CoV-2 circulation in human population. Herein, we aimed to review the probable risk of intrauterine vertical transmission of SARS-CoV-2 infection to the fetus, its adverse outcomes during pregnancy for both mother and the fetus and maternal risk factors which affect the severity Coronavirus disease 2019 (COVID-19.